Arylacetamide deacetylase (AADAC)

Displays cellular triglyceride lipase activity in liver, increases the levels of polyunsaturated fatty acids derived from the hydrolysis of newly formed triglyceride stores and plays a part in rather low-density lipoprotein assembly. Displays serine esterase activity in liver.

Deacetylates a variety of arylacetamide substrates, including xenobiotic compounds and procarcinogens, converting them to the primary arylamide compounds and increasing their toxicity. .